Hybridization of CRLF2 break / IGH fusion probe to a metaphase spread showing normal pattern (2RG2B).
Hybridization of CRLF2 break / IGH fusion probe to a metaphase spread showing normal pattern (2RG2B).
IVD CRLF2/IGH
CRLF2-IGH fusions between Xp22-14q32 or Yp11-14q32 results in a deregulated expression of the cytokine receptor gene (CRLF2). This can also be the result of the fusion with the P2RY8 promoter on Xp22 or Yp11. Gain of chromosome X has been observed in Down syndrome-associated ALL. The CRLF2 (Xp22/Yp11) Break/IGH (14q32) Fusion Triple-Color FISH probe is optimized to detect translocations involving the CRLF2 gene at region Xp22 and Yp11. The probe shows a break between red and green in case of a translocation with CRLF2 and IGH involvement. In case of a fusion with the P2RY8 gene on Xp22 or Yp11, one red probe is deleted. For fusion confirmation to the IGH gene, a blue probe covering IGH is added.
References: Mullighan et al., 2009, Nat. Genet. 41(11): 1243-1246. Russell et al., 2009, Blood, 114(13): 2688-2698.
Products
Products
KBI-10406
CRLF2 (Xp22/Yp11) Break / IGH Fusion,TC
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.